1. Accueil
  2. EN
  3. Studying at ULB
  4. Find your course

Master in Biomedical Sciences (60 credits)

Master in Biomedical Sciences (60 credits)

This formation is taught in english.

The 2020-2021 programme is subject to change. It is provided for information purposes only.

Accéder aux sections de la fiche

Call to actions

  • Programme title
    Master in Biomedical Sciences (60 credits)
  • Programme mnemonic
  • Programme organised by
    • Faculty of Medicine
  • Degree type
    Masters 60 credits
  • Tier
    2nd cycle
  • Field and branch of study
    Health/Biomedical and pharmaceutical sciences
  • Schedule type
  • Languages of instruction
  • Theoretical programme duration
    1 year
  • Campus
  • Category / Topic
    Health - Biomedical and pharmaceutical sciences
  • Jury President
    Isabelle PIRSON
  • Jury Secretary


General information

Degree type

Masters 60 crédits

Theoretical programme duration

1 year

Learning language(s)


Schedule type




Category(ies) - Topic(s)

Health - Biomedical and pharmaceutical sciences

Organising faculty(s) and university(ies)


Personalized medicine aims to transform healthcare by tailoring therapies to the individual characteristics and needs of each patient. This requires an efficient translation of fundamental research findings into standard care.

The short master in translational medicine is a one-year (60 credits), full English programme designed to train students in medical and biomedical sciences or associated areas on how to apply relevant findings derived from fundamental research into newly patient-oriented diagnostic approaches and therapies.

This program offers substantial formation in pre-clinical and clinical aspects of the personalized medicine, as well as fundamental knowledge and interdisciplinary skills necessary to interact with experts and colleagues from a wide range of disciplines that will shape the future of medicine.

During the first quadrimester, the courses will be given by researchers active in the fields in different Academic laboratories of the Medicine Faculty. They focus their courses on concrete cases based on actual scientific research.

The second part of the year is led by teachers from multiple faculties and stakeholders from public and industrial institutions who share with the students their professional experience in different areas of healthcare and medical innovation. Students will thus be prepared to start a career in various public or private professional environments.

The MA in Biomedical sciences (60 credits) is inspired by new initiatives aiming to develop translational research programs to foster the transfer of scientific preclinical knowledge into clinical practice to make personalized medicine became a reality.

Taught exclusively in English, the MA 60 will allow non-French speaking students to extend their basic training and to prepare a doctorate in one of the Faculty’s laboratories and/or an internship in one of our hospital services.

Moreover, by attending the I nterdisciplinary and interfaculty program in Translational medicine, students will have professional opportunities through contacts with stakeholders from public institutions and private companies.

Given in English and in one year, the Master offers a rapid way to access international careers in health institutions and companies.

Access conditions


During the first quadrimester, the students will foster their knowledge on the molecular aspects of pharmacology, clinical biology and pathology, genetics and oncology, developmental genetics, bioinformatics, and neurosciences.

During the second quadrimester they will achieve a Master thesis and attend:

  • A unique interdisciplinary and interfaculty program in Translational medicine covering preclinical, clinical, regulatory, patenting, business, management and patient-focused topics.

  • A module on pre-clinical and clinical research providing insights in state-of-the-art in vitro and in vivo research tools and methods to perform translational research and in the choice of adequate research models and proper experimental design. The module will also cover current and innovative technologies for drug discovery, in vitro and in vivo pre-clinical safety assessment of newly discovered drugs, and their validation through clinical trials. Intellectual property, clinical study design, quality control, as well as legal and ethical requirements in clinical investigation will also be discussed.

  • A module on translational research in selected disease areas that will illustrate the bed-to-bench and back again (3B) principle of translational medicine through the approach of case-studies in relevant diseases.

What's next ?


The graduated students in Biomedical sciences - translational medicine will be able to pursue careers in health institutions and companies e.g: biotech and pharmaceutical industries, contract research organizations, governmental and non-governmental organizations (e.g. regulatory agencies), patient associations.

Important: to access a PhD training, the short-term Master must be accompanied/completed by a long-term (120 credits) Master's degree in a relevant discipline.

Of note, 45 credits of the short-term Master training can be validated in the program of the long-term Master in Biomedical sciences.